Lysophosphatidylcholine Potentiates the Mitogenic Effect of Various Vasoactive Compounds on Rabbit Aortic Smooth Muscle Cells.
- 1 January 2002
- journal article
- Published by International Heart Journal (Japanese Heart Journal) in Japanese Heart Journal
- Vol. 43 (4) , 409-416
- https://doi.org/10.1536/jhj.43.409
Abstract
We examined the mechanism of action of lysophosphatidylcholine (lyso-PC), which is suggested to be involved in the pathogenesis of atherosclerosis and inflamatory disorders, and its interaction with well-known vasoactive compounds such as hydrogen peroxide (H2O2), thromboxane A2 (TX-A2), serotonin (5-HT), angiotensin II (Ang-II), endothelin-1 (ET-1), or urotensin II (U-II) on VSMC proliferation. Growth-arrested rabbit VSMCs were incubated with given concentrations of lyso-PC with H202, TX-A2, 5-HT, Ang-II, ET-1, or U-II. [3H]Thymidine incorporation into DNA was measured as an index of VSMC proliferation. Lyso-PC induced a maximal effect on [3H]thymidine incorporation at a concentration of 15 microM (156%), and its effect was significantly inhibited by the phospholipase C inhibitor U73122 (10 microM), the intracellular antioxidant NAC (400 microM), and the NADPH oxidase inhibitor diphenylene iodonium (1 microM), but not by the MAPK kinase inhibitor (10 microM). H2O2, TX-A2, 5-HT, Ang-II, ET-1, or U-II also stimulated [3H]thymidine incorporation in a dose-dependent manner. A non-mitogenic concentration of lyso-PC (5 microM) significantly potentiated the effect of low concentrations of H2O2 (0.1 microM, 110 to 222%), TX-A2 (5 microM, 120 to 202%), 5-HT (5 microM, 182 to 259%), Ang-II (0.5 microM, 167 to 304%), ET-1 (0.01 microM, 139 to 297%), or U-II (0.025 microM, 120 to 332%) on [3H]thymidine incorporation. The results suggest that lyso-PC acts synergistically with the vasoactive compounds H2O2, TX-A2, 5-HT, Ang-II, ET-1, or U-II in inducing VSMC proliferation, which may play an important role in the progression of atherosclerosis.Keywords
This publication has 36 references indexed in Scilit:
- Lysophosphatidylcholine Is a Major Contributor to the Synergistic Effect of Mildly Oxidized Low-Density Lipoprotein With Endothelin-1 on Vascular Smooth Muscle Cell ProliferationJournal of Cardiovascular Pharmacology, 2002
- Oxidized Low-Density Lipoproteins Potentiate the Mitogenic Effect of 5-Hydroxytryptamine on Vascular Smooth Muscle Cells.Japanese Heart Journal, 2002
- Synergistic interaction between thromboxane A2and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferationProstaglandins, Leukotrienes & Essential Fatty Acids, 2000
- Endothelin-1 and Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Src and Cas Mediate JNK Activation but Not ERK1/2 and p38 Kinases by Reactive Oxygen SpeciesJournal of Biological Chemistry, 2000
- Active Oxygen Species and Lysophosphatidylcholine Are Involved in Oxidized Low Density Lipoprotein Activation of Smooth Muscle Cell DNA SynthesisArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine.Journal of Clinical Investigation, 1995
- Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cellsAtherosclerosis, 1995
- Beyond CholesterolNew England Journal of Medicine, 1989
- Studies on ether phospholipidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984